FR2164900B1 - - Google Patents

Info

Publication number
FR2164900B1
FR2164900B1 FR7245990A FR7245990A FR2164900B1 FR 2164900 B1 FR2164900 B1 FR 2164900B1 FR 7245990 A FR7245990 A FR 7245990A FR 7245990 A FR7245990 A FR 7245990A FR 2164900 B1 FR2164900 B1 FR 2164900B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7245990A
Other languages
French (fr)
Other versions
FR2164900A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HARTENBACH WALTER
Original Assignee
HARTENBACH WALTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HARTENBACH WALTER filed Critical HARTENBACH WALTER
Publication of FR2164900A1 publication Critical patent/FR2164900A1/en
Application granted granted Critical
Publication of FR2164900B1 publication Critical patent/FR2164900B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7245990A 1971-12-24 1972-12-22 Carcinostatic immunogammaglobulin prodn - from blood of animals injected with human cancer-cells Granted FR2164900A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2164565A DE2164565A1 (en) 1971-12-24 1971-12-24 METHOD OF OBTAINING ANTI-CANCER SUBSTANCES

Publications (2)

Publication Number Publication Date
FR2164900A1 FR2164900A1 (en) 1973-08-03
FR2164900B1 true FR2164900B1 (en) 1976-07-02

Family

ID=5829213

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7245990A Granted FR2164900A1 (en) 1971-12-24 1972-12-22 Carcinostatic immunogammaglobulin prodn - from blood of animals injected with human cancer-cells

Country Status (4)

Country Link
JP (1) JPS4868733A (en)
CH (1) CH574246A5 (en)
DE (1) DE2164565A1 (en)
FR (1) FR2164900A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO793412L (en) * 1978-10-25 1980-05-06 Benzon As Alfred PROCEDURE FOR PREPARING TRANSFER FACTOR AGAINST PATHOGEN ANTIGEN

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE691940C (en) * 1932-12-10 1940-06-08 Maria Katharina Remmets Geb Re Process for making a cancer serum

Also Published As

Publication number Publication date
DE2164565A1 (en) 1973-06-28
JPS4868733A (en) 1973-09-19
FR2164900A1 (en) 1973-08-03
CH574246A5 (en) 1976-04-15

Similar Documents

Publication Publication Date Title
ATA136472A (en)
AR196074A1 (en)
FR2164900B1 (en)
AU2485671A (en)
AU2894671A (en)
AU2941471A (en)
AU2952271A (en)
AU2564071A (en)
AU3005371A (en)
AU2577671A (en)
AU3038671A (en)
AU2415871A (en)
AU2455871A (en)
AU2836771A (en)
AU2473671A (en)
AU2875571A (en)
AU2880771A (en)
AU2654071A (en)
AU2885171A (en)
AU1109576A (en)
AU2907471A (en)
AU2927871A (en)
AU2930871A (en)
AU2486471A (en)
AU2938071A (en)

Legal Events

Date Code Title Description
ST Notification of lapse